A Study Of Oral Paricalcitol To Treat Proteinuric Renal Disease
NCT00469625
·
clinicaltrials.gov ↗
NA
Phase
WITHDRAWN
Status
OTHER
Sponsor class
Stopped
Investigator left the Institution.
Conditions
Proteinuric Renal Disease
Interventions
DRUG:
paricalcitol (initial dose 1 mcg orally per day)
Sponsor
Winthrop University Hospital